BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interleukin-1 receptor-like 1 (IL1RL1; ST2)

November 5, 2015 8:00 AM UTC

Mouse studies suggest inhibiting soluble IL1RL1 could help treat GvHD after allogeneic hematopoietic cell transplantation. Plasma levels of soluble IL1RL1 were higher in mice that received transplants...